170 related articles for article (PubMed ID: 14532284)
1. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.
Atkinson PG; Coope HJ; Rowe M; Ley SC
J Biol Chem; 2003 Dec; 278(51):51134-42. PubMed ID: 14532284
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.
Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS
Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817
[TBL] [Abstract][Full Text] [Related]
3. CD40 regulates the processing of NF-kappaB2 p100 to p52.
Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
[TBL] [Abstract][Full Text] [Related]
5. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.
Hatada EN; Do RK; Orlofsky A; Liou HC; Prystowsky M; MacLennan IC; Caamano J; Chen-Kiang S
J Immunol; 2003 Jul; 171(2):761-8. PubMed ID: 12847243
[TBL] [Abstract][Full Text] [Related]
6. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
7. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins.
Paine E; Scheinman RI; Baldwin AS; Raab-Traub N
J Virol; 1995 Jul; 69(7):4572-6. PubMed ID: 7769726
[TBL] [Abstract][Full Text] [Related]
8. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.
Saito N; Courtois G; Chiba A; Yamamoto N; Nitta T; Hironaka N; Rowe M; Yamamoto N; Yamaoka S
J Biol Chem; 2003 Nov; 278(47):46565-75. PubMed ID: 12968033
[TBL] [Abstract][Full Text] [Related]
9. Oncogenes, tumor suppressors and p52 NF-kappaB.
Perkins ND
Oncogene; 2003 Oct; 22(48):7553-6. PubMed ID: 14576816
[TBL] [Abstract][Full Text] [Related]
10. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.
Pai S; O'Sullivan BJ; Cooper L; Thomas R; Khanna R
J Virol; 2002 Feb; 76(4):1914-21. PubMed ID: 11799186
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1 Tax enhances NF-kappa B2 expression and binds to the products p52 and p100, but does not suppress the inhibitory function of p100.
Murakami T; Hirai H; Suzuki T; Fujisawa J; Yoshida M
Virology; 1995 Feb; 206(2):1066-74. PubMed ID: 7856081
[TBL] [Abstract][Full Text] [Related]
12. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.
Mordmüller B; Krappmann D; Esen M; Wegener E; Scheidereit C
EMBO Rep; 2003 Jan; 4(1):82-7. PubMed ID: 12524526
[TBL] [Abstract][Full Text] [Related]
13. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
[TBL] [Abstract][Full Text] [Related]
14. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation.
Li Y; Sedwick CE; Hu J; Altman A
J Biol Chem; 2005 Jan; 280(2):1217-23. PubMed ID: 15536066
[TBL] [Abstract][Full Text] [Related]
15. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
[TBL] [Abstract][Full Text] [Related]
16. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
17. RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100.
Derudder E; Dejardin E; Pritchard LL; Green DR; Korner M; Baud V
J Biol Chem; 2003 Jun; 278(26):23278-84. PubMed ID: 12709443
[TBL] [Abstract][Full Text] [Related]
18. Regulation of NF-kappa B2 p100 processing by its cis-acting domain.
Qing G; Qu Z; Xiao G
J Biol Chem; 2005 Jan; 280(1):18-27. PubMed ID: 15485830
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.
Kung CP; Raab-Traub N
J Virol; 2008 Jun; 82(11):5486-93. PubMed ID: 18367518
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
Huen DS; Henderson SA; Croom-Carter D; Rowe M
Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
